This was despite the fact that there were no cash bonuses and in that category Debes had $613,844 last year; Schulz, $85,605; Balmforth, $21,574 and Hager, $184,018. Much of the increases came from the non-equity incentives with Debes drawing $812,500 from that source, up from $41,308 the prior year. And except for Debes, these guys got decent boosts in their base salary. Balmforth's base rose to $300,000, a 20-percent increase, and Hager got $320,000, up 15.8 percent. This probably follows the compensation policy endorsed in the Marx Brothers' film, "A Night at the Opera." "In all that time, you've done nothing but draw a very handsome salary." "You think that's nothing? How many men do you think draw a handsome salary? You can count them on the fingers of one hand, my good woman." To be fair (why start now?), the company is shifting gears with its January purchase of HealthVision. One help to margins was probably that there were 20 deals of more than $1 million in license fees in FY 2010, compared to nine the prior year.